TrmB, a tRNA m7G46 methyltransferase, plays a role in hydrogen peroxide resistance and positively modulates the translation of katA and katB mRNAs in Pseudomonas aeruginosa. Thongdee N, Jaroensuk J, Atichartpongkul S, Chittrakanwong J, Chooyoung K, Srimahaeak T, Chaiyen P, Vattanaviboon P, Mongkolsuk S, Fuangthong M. Nucleic Acids Res. 2019 Sep 26;47(17):9271-9281. doi: 10.1093/nar/gkz702. PMID: 31428787

28 Dec 2019
0
0

TrmB, a tRNA m7G46 methyltransferase, plays a role in hydrogen peroxide resistance and positively modulates the translation of katA and katB mRNAs in Pseudomonas aeruginosa.
Thongdee N, Jaroensuk J, Atichartpongkul S, Chittrakanwong J, Chooyoung K, Srimahaeak T, Chaiyen P, Vattanaviboon P, Mongkolsuk S, Fuangthong M.
Nucleic Acids Res. 2019 Sep 26;47(17):9271-9281. doi: 10.1093/nar/gkz702.
PMID: 31428787

Tags

Share this

Related Posts

Ganihigama, D. U.; Sureram, S.; Sanghe,r S.; Hongmanee, P.; Aree, T.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads Against Clinical Multidrug Resistant Isolates of Mycobacterium tuberculosis. Eur. J. Med. Chem. 2015, 89, 1-12.
28 Dec 2015
0

Ganihigama, D. U.; Sureram, S.; Sanghe,r S.; Hongmanee, P.; Aree, T.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads Against Clinical Multidrug Resistant Isolates of Mycobacterium tuberculosis. Eur. J. Med. Chem. 2015, 89, 1-12.

Ganihigama, D. U.; Sureram, S.; Sanghe,r S.; Hongmanee, P.; Aree, T.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Antimycobacterial Activity of Natural Products and Synthetic Agents: Pyrrolodiquinolines and Vermelhotin as Anti-Tubercular Leads Against Clinical Multidrug Resistant Isolates of Mycobacterium tuberculosis. Eur. J. Med. Chem. 2015, 89, 1-12.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More